Skip to Main Content

Paper Details

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.
Cancer Prev Res (Phila)
26
2022
Author NameAffiliation
Patrick J MorrisonQueens University Belfast, Belfast City Hospital HSC Trust
David J BurnNewcastle University Translational and Clinical Research Institute
  • 1 - 2

Datasets

Release 1.2